214 related articles for article (PubMed ID: 31218146)
1. Clinical Efficacy and Safety Profile of Prucalopride in Chronic Idiopathic Constipation.
Tameez Ud Din A; Khan AH; Bajwa H; Maqsood MH; Malik MN
Cureus; 2019 Apr; 11(4):e4382. PubMed ID: 31218146
[TBL] [Abstract][Full Text] [Related]
2. Use of prucalopride in adults with chronic idiopathic constipation.
Vijayvargiya P; Camilleri M
Expert Rev Clin Pharmacol; 2019 Jul; 12(7):579-589. PubMed ID: 31096799
[No Abstract] [Full Text] [Related]
3. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
Gale JD
Adv Ther; 2009 May; 26(5):519-30. PubMed ID: 19444393
[TBL] [Abstract][Full Text] [Related]
4. Prucalopride: A Review in Chronic Idiopathic Constipation.
Garnock-Jones KP
Drugs; 2016 Jan; 76(1):99-110. PubMed ID: 26628294
[TBL] [Abstract][Full Text] [Related]
5. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.
Tack J; van Outryve M; Beyens G; Kerstens R; Vandeplassche L
Gut; 2009 Mar; 58(3):357-65. PubMed ID: 18987031
[TBL] [Abstract][Full Text] [Related]
6. A Review of the Cardiovascular Safety of Prucalopride in Patients With Chronic Idiopathic Constipation.
Tack J; Derakhchan K; Gabriel A; Spalding W; Terreri B; Youssef A; Kreidieh B; Kowey PR; Boules M
Am J Gastroenterol; 2023 Jun; 118(6):955-960. PubMed ID: 36927957
[TBL] [Abstract][Full Text] [Related]
7. Novel therapies for constipation.
Thayalasekeran S; Ali H; Tsai HH
World J Gastroenterol; 2013 Dec; 19(45):8247-51. PubMed ID: 24363515
[TBL] [Abstract][Full Text] [Related]
8. An overview of the efficacy and safety of prucalopride for the treatment of chronic idiopathic constipation.
Daniali M; Nikfar S; Abdollahi M
Expert Opin Pharmacother; 2019 Dec; 20(17):2073-2080. PubMed ID: 31557072
[No Abstract] [Full Text] [Related]
9. A placebo-controlled trial of prucalopride for severe chronic constipation.
Camilleri M; Kerstens R; Rykx A; Vandeplassche L
N Engl J Med; 2008 May; 358(22):2344-54. PubMed ID: 18509121
[TBL] [Abstract][Full Text] [Related]
10. Patient considerations in the management of chronic constipation: focus on prucalopride.
Shin A
Patient Prefer Adherence; 2016; 10():1373-84. PubMed ID: 27528801
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis.
Luthra P; Camilleri M; Burr NE; Quigley EMM; Black CJ; Ford AC
Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):831-844. PubMed ID: 31474542
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of oral prucalopride in women with chronic constipation in whom laxatives have failed: an integrated analysis.
Tack J; Quigley E; Camilleri M; Vandeplassche L; Kerstens R
United European Gastroenterol J; 2013 Feb; 1(1):48-59. PubMed ID: 24917940
[TBL] [Abstract][Full Text] [Related]
13. Prucalopride: the evidence for its use in the treatment of chronic constipation.
Coremans G
Core Evid; 2008 Jun; 3(1):45-54. PubMed ID: 20694083
[TBL] [Abstract][Full Text] [Related]
14. Prucalopride: a review of its use in the management of chronic constipation.
Keating GM
Drugs; 2013 Nov; 73(17):1935-50. PubMed ID: 24194435
[TBL] [Abstract][Full Text] [Related]
15. Safety/Efficacy of Prucalopride in Korean Patients with Chronic Constipation: Post-marketing Surveillance.
Yeon SE; Kim SY; Chung WC; Jeon SW; Park SJ; Choi CH; Choi MG
Korean J Gastroenterol; 2021 Oct; 78(4):219-226. PubMed ID: 34697276
[TBL] [Abstract][Full Text] [Related]
16. [Some practical questions on chronic stipsis treatment with prucalopride].
Bellacosa L; Cogliandro R; Cremon C; De Giorgio R; Barbara G; Stanghellini V
Minerva Gastroenterol Dietol; 2014 Mar; 60(1):85-99. PubMed ID: 24632771
[TBL] [Abstract][Full Text] [Related]
17. Oral prucalopride in children with functional constipation.
Winter HS; Di Lorenzo C; Benninga MA; Gilger MA; Kearns GL; Hyman PE; Vandeplassche L; Ausma J; Hoppenbrouwers M
J Pediatr Gastroenterol Nutr; 2013 Aug; 57(2):197-203. PubMed ID: 23535761
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety analysis of prucalopride in refractory chronic constipation cases in a tertiary care hospital in Eastern India: A randomized, single-blind, placebo-controlled study.
Dehury S; Mohapatra S; Das HS; Goutam S; Kaushik C
Indian J Pharmacol; 2023; 55(1):6-13. PubMed ID: 36960515
[TBL] [Abstract][Full Text] [Related]
19. Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study.
Vigone B; Caronni M; Severino A; Bellocchi C; Baldassarri AR; Fraquelli M; Montanelli G; Santaniello A; Beretta L
Arthritis Res Ther; 2017 Jun; 19(1):145. PubMed ID: 28633671
[TBL] [Abstract][Full Text] [Related]
20. An update on prucalopride in the treatment of chronic constipation.
Omer A; Quigley EMM
Therap Adv Gastroenterol; 2017 Nov; 10(11):877-887. PubMed ID: 29147138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
